These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Immune responses to herpes simplex virus in patients with recurrent herpes labialis: I. Development of cell-mediated cytotoxic responses. Tsutsumi H; Bernstein JM; Riepenhoff-Talty M; Cohen E; Orsini F; Ogra PL Clin Exp Immunol; 1986 Dec; 66(3):507-15. PubMed ID: 2436840 [TBL] [Abstract][Full Text] [Related]
3. Herpes simplex virus-specific immune responses in subjects with frequent and infrequent orofacial recrudescences. McKenna DB; Neill WA; Norval M Br J Dermatol; 2001 Mar; 144(3):459-64. PubMed ID: 11259999 [TBL] [Abstract][Full Text] [Related]
4. Studies on human epidermal Langerhans' cells: II. Activation of human T lymphocytes to herpes simplex virus. Braathen LR; Berle E; Mobech-Hanssen U; Thorsby E Acta Derm Venereol; 1980; 60(5):381-7. PubMed ID: 6162307 [TBL] [Abstract][Full Text] [Related]
5. Immune-specific interferon production by peripheral blood mononuclear leukocytes from patients with primary and recurrent oro-labial herpes simplex virus infections. Green JA; Weiss PN; Yeh TJ; Spruance SL J Med Virol; 1985 Jul; 16(3):297-305. PubMed ID: 2993500 [TBL] [Abstract][Full Text] [Related]
6. Immune response to herpes simplex virus in patients with recurrent herpes labialis. II. Relationship between interferon production and cytotoxic responses. Tsutsumi H; Bernstein JM; Riepenhoff-Talty M; Ogra PL Pediatr Res; 1986 Sep; 20(9):905-8. PubMed ID: 3018660 [TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy of a herpes simplex subunit vaccine. Cappel R; Sprecher S; De Cuyper F; De Braekeleer J J Med Virol; 1985 Jun; 16(2):137-45. PubMed ID: 2989419 [TBL] [Abstract][Full Text] [Related]
8. Immunostimulatory function of herpes simplex virus isolates from patients with frequent herpes labialis and a deficiency in immune-specific interferon production. Klieman RL; Green JA; Spruance SL J Med Virol; 1985 Jul; 16(3):289-96. PubMed ID: 2993499 [TBL] [Abstract][Full Text] [Related]
9. Cellular immune responses to Herpes simplex virus type 1 in recurrent herpes labialis: in vitro blastogenesis and cytotoxicity to infected cell line. Steele RW; Vincent MM; Hensen SA; Fuccillo DA; Chapa IA; Canales L J Infect Dis; 1975 May; 131(5):528-34. PubMed ID: 165245 [TBL] [Abstract][Full Text] [Related]
10. Lymphocyte responses to herpes simplex virus isolates from patients with primary and recurrent herpes simplex genitalis. Reichman RC; Fisher SE; Dolin R Am J Med; 1982 Jul; 73(1A):86-90. PubMed ID: 6285740 [TBL] [Abstract][Full Text] [Related]
11. Detection of herpes simplex virus DNA in the peripheral blood during acute recurrent herpes labialis. Brice SL; Stockert SS; Jester JD; Huff JC; Bunker JD; Weston WL J Am Acad Dermatol; 1992 Apr; 26(4):594-8. PubMed ID: 1317892 [TBL] [Abstract][Full Text] [Related]
12. Recurrent infection with herpes simplex virus after marrow transplantation: role of the specific immune response and acyclovir treatment. Wade JC; Day LM; Crowley JJ; Meyers JD J Infect Dis; 1984 May; 149(5):750-6. PubMed ID: 6327849 [TBL] [Abstract][Full Text] [Related]
13. Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type. Lafferty WE; Coombs RW; Benedetti J; Critchlow C; Corey L N Engl J Med; 1987 Jun; 316(23):1444-9. PubMed ID: 3033506 [TBL] [Abstract][Full Text] [Related]
14. Sequential changes in cell-mediated immune responses to herpes simplex virus after recurrent herpetic infection in humans. Shillitoe EJ; Wilton JM; Lehner T Infect Immun; 1977 Oct; 18(1):130-7. PubMed ID: 198372 [TBL] [Abstract][Full Text] [Related]
15. Human T cell response to Herpes simplex virus antigen in vitro. Berle EJ; Thorsby E Acta Pathol Microbiol Scand C; 1980 Feb; 88(1):31-7. PubMed ID: 6246714 [TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of herpes simplex labialis. I. Replication of herpes simplex virus in cultures of epidermal cells from subjects with frequent recurrences. Spruance SL; Chow FS J Infect Dis; 1980 Nov; 142(5):671-5. PubMed ID: 6257796 [TBL] [Abstract][Full Text] [Related]
17. Clinical and serological outcome of genital herpes simplex virus (HSV) type 2 inoculation following oral HSV type 1 infection in guinea-pigs. Bernstein DI; Lee FK; Echler G; Nahmias AJ J Gen Virol; 1989 Sep; 70 ( Pt 9)():2365-72. PubMed ID: 2550572 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of mitogen- and antigen-induced lymphocyte blastogenesis by herpes simplex virus. Plaeger-Marshall S; Smith JW J Infect Dis; 1978 Oct; 138(4):506-11. PubMed ID: 213497 [TBL] [Abstract][Full Text] [Related]
19. Spontaneous and induced interferon production by peripheral blood leucocytes from control population and patients with herpes genitalis. Iannello D; Taylor MW; Fife KH; Chen L J Med Virol; 1987 May; 22(1):25-34. PubMed ID: 3035077 [TBL] [Abstract][Full Text] [Related]
20. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities. Yasukawa M; Zarling JM J Immunol; 1984 Nov; 133(5):2736-42. PubMed ID: 6207243 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]